Please login to the form below

Not currently logged in
Email:
Password:

INC Research promotes Susan Akers-Smith to senior oncology role

She takes up the position of VP of early phase oncology development

Contract research organisation (CRO) INC Research has promoted Susan Akers-Smith to VP of early phase oncology development.

She joined the CRO in 2004, holding a series of oncology-focused roles and serving most recently as executive director of clinical development in oncology.

Nicholas Kenny, executive VP and general manager, global oncology and haematology at INC Research, said: "We are thrilled to recognise Susan's individual efforts, creativity and performance through this well-deserved promotion.

"We always strive to combine operational efficiency with the latest advancements in medical and regulatory knowledge to conduct cancer trials of the highest quality. Susan epitomises the leadership traits necessary for this role and we look forward to leveraging her experience to further support the growing early phase oncology research needs of our customers."

Akers-Smith brings to her new role more than a decade of management experience in the CRO industry focused on early phase oncology development, with therapeutic experience including a broad range of study designs and tumour types.

Prior to working in the CRO industry, she worked in emergency healthcare and served in the US Army Reserve.

6th September 2012

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...

Infographics